Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Carter Todd Alfred
Chief Scientific Officer at Voyager Therapeutics. Filing since 6 Jan 2023.
CIK 0001944011
Company
Date
Role
Action
Shares
Amount
Of holding
VYGR
Voyager Therapeutics, Inc.
24 Feb 2026
Chief Scientific Officer
Sold on a plan
4,174
$15.69K
2.8%
VYGR
Voyager Therapeutics, Inc.
18 Feb 2026
Chief Scientific Officer
Sold on a plan
3,301
$11.36K
2.2%
VYGR
Voyager Therapeutics, Inc.
10 Feb 2026
Chief Scientific Officer
Sold at will
3,525
$13.57K
2.2%
VYGR
Voyager Therapeutics, Inc.
20 Feb 2025
Chief Scientific Officer
Sold at will
3,305
$14.08K
4.1%
VYGR
Voyager Therapeutics, Inc.
11 Feb 2025
Chief Scientific Officer
Sold at will
5,413
$24.09K
6.3%
VYGR
Voyager Therapeutics, Inc.
14 Jan 2025
Chief Scientific Officer
Sold at will
1,191
$6.11K
1.4%
VYGR
Voyager Therapeutics, Inc.
21 Feb 2024
Chief Scientific Officer
Sold at will
3,365
$25.14K
3.7%
VYGR
Voyager Therapeutics, Inc.
20 Feb 2024
Chief Scientific Officer
Sold at will
602
$4.62K
0.7%
VYGR
Voyager Therapeutics, Inc.
17 Jan 2024
Chief Scientific Officer
Sold at will
1,266
$9.09K
2.3%
VYGR
Voyager Therapeutics, Inc.
15 Sep 2023
Chief Scientific Officer
Sold on a plan
10,500
$85.68K
16.2%
VYGR
Voyager Therapeutics, Inc.
6 Jul 2023
Chief Scientific Officer
Sold on a plan
5,500
$59.40K
8.4%
VYGR
Voyager Therapeutics, Inc.
30 Jun 2023
Chief Scientific Officer
Sold on a plan
5,000
$57.05K
7.1%
VYGR
Voyager Therapeutics, Inc.
20 Mar 2023
Chief Scientific Officer
Sold at will
2,193
$17.02K
3.2%
VYGR
Voyager Therapeutics, Inc.
17 Feb 2023
Chief Scientific Officer
Sold, plan not stated
738
$5.50K
1.1%
VYGR
Voyager Therapeutics, Inc.
13 Feb 2023
Chief Scientific Officer
Sold, plan not stated
797
$6.11K
2.3%
VYGR
Voyager Therapeutics, Inc.
17 Jan 2023
Chief Scientific Officer
Sold, plan not stated
1,106
$10.89K
3.1%
VYGR
Voyager Therapeutics, Inc.
6 Jan 2023
Chief Scientific Officer
Sold, plan not stated
388
$2.49K
1.1%
17 decisions on file.
